354P NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302)
Autor: | Coveler, A., Skolariki, A., Ciombor, K.K., Marijon Jourdier, H., Graham, J., Peters, M.L., Cohen, S.A., Myers, M., Oelmann, E.M., Bloss, J., Blagden, S.P., de Gramont, A., Berlin, J.D., Evans, T.R.J. |
---|---|
Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S697-S698 |
Databáze: | ScienceDirect |
Externí odkaz: |